Navigation Links
Simple idea to dramatically improve dengue vaccinations

s when the immune system identifies infected cells and brings pieces of them into the lymph node for targeting. Within a few days of infection, the immune system completes a massive scan of the 100 million available T-cells in its arsenal. Through a complex trial-and-error process, it identifies three to five T-cells that best recognize and attack the components of the sickened cells. Once the cells are selected, they are produced by the millions and sent out to clear the infection. After the infection is gone, thousands of these pre-programmed T-cells remain in the body, lying in wait should the disease return.

In recent years, public health officials have documented the disturbing co-existence of two or more Dengue viruses in Brazil, Cuba, Thailand, and other tropical and subtropical countries. Because sequential infection by multiple Dengue viruses can lead to increased likelihood of deadly infections, public health officials have attempted to counter the threat of co-existent versions of Dengue by developing a vaccine against all four versions simultaneously. Doctors found that patients who got a four-component vaccine wound up only being protected against one or two versions at most, due to immunodominance.

Intrigued by these results, Deem and graduate student Hao Zhou developed a precise computer model of the immune system's biochemical scanning process to see if they could recreate the effect and find out what caused it. Their program conducts statistical calculations about the likelihood of specific interactions at the atomic level. They conducted trillions of calculations and gradually built up a bigger picture of what occurs in Dengue immunodominance.

"When faced with more than one version of the virus, the immune system may respond preferentially against the version for which it has T-cells with the strongest affinity, which is immunodominance," Deem said.

He said polytopic vaccination ?giving different vaccines simultaneou
'"/>

Source:Rice University


Page: 1 2 3

Related biology news :

1. Simple drug has the potential to save many lives threatened by malaria
2. Discovery Promises Simpler Therapy for Sickle Cell Disease
3. Simple sea sponge helps scientists understand tissue rejection
4. Simple explanation for complex pattern of feather development
5. Simple home spit test to spot deadly pre-eclampsia
6. New miniaturised chip dramatically reduces time taken for DNA analysis
7. Caloric restriction wont dramatically extend life span in humans: UCLA research
8. Hospitalizations because of chicken pox down dramatically since implementation of vaccine
9. Lack of a key enzyme dramatically increases resistance to sepsis
10. Smoking ban dramatically reduces air pollution in Irish pubs
11. Growing nerve cells in 3-D dramatically affects gene expression

Post Your Comments:
(Date:11/23/2009)...research suggests that a common oral bacterium may...t by Nichols et al, "Unique Lipids from a Common H...ds Capable of Enhancing Autoimmunity," appears in ...f Pathology . , Multiple sclerosis (MS), a disea...pinal cord, affects nearly 1 in 700 people in the ...
(Date:11/23/2009)...swine vaccine available for the H1N1 virus has bee... virus. The vaccination marks the first time vacci...e pandemic flu., Iowa State University,s Hank Ha...accine this summer and has been shipping preventiv...inois for several weeks., The latest vaccines we...
(Date:11/23/2009)..., 2009 -- A USDOE and USDA study concluded that 50...d cropland pasture could be converted from current... as switchgrass, from which biomass could be harve...viable production of a perennial grass monoculture...removed annually is expected to require nitrogen f...
Breaking Biology News(10 mins):Factors from common human bacteria may trigger multiple sclerosis 2Iowa State researcher produces, ships only H1N1 vaccine available for swine 2Switchgrass produces biomass efficiently 2How Well Do You Sleep At Night 3F Visit The New Online Aviisha Medical Wellness Institute To Find Out 54874 1How Well Do You Sleep At Night 3F Visit The New Online Aviisha Medical Wellness Institute To Find Out 54874 2How Well Do You Sleep At Night 3F Visit The New Online Aviisha Medical Wellness Institute To Find Out 54874 3Misuse of Pain Medication Draws Heightened Concerns 54870 1Misuse of Pain Medication Draws Heightened Concerns 54870 2Misuse of Pain Medication Draws Heightened Concerns 54870 3Misuse of Pain Medication Draws Heightened Concerns 54870 4Anthem Blue Cross and Blue Shield in Maine Announces Decision to Cover H1N1 Vaccine Administration 54866 1Anthem Blue Cross and Blue Shield in Maine Announces Decision to Cover H1N1 Vaccine Administration 54866 2
...ch sun ?for plants as well as people ?can be harmf... equivalent of "lobster tans," plants have develop... photoprotection, which acts like sunscreen to war...olecules called carotenoids participate in this pr...n, how does this work?" said Iris Visoly-Fisher, a...
...e first time, researchers have developed a way to ...in in enough quantity to learn how it works. , Der...s of a New Zealand cave, the chemical tricks certa... cells untouched. , "In 2000, scientists in Japan...mendous potential as a prototype anticancer agent,...
...g a whole new interface between nanotechnology and...ve used slender silicon nanowires to detect, stimu...d dendrites of live mammalian neurons. , Harvard ... this marriage of nanowires and neurons this week ... artificial synapses between nanoelectronic device...
Other Biology News:How plants avoid feeling the burn 2How plants avoid feeling the burn 3How plants avoid feeling the burn 4New lab technique churns out fungus' potential cancer fighter 2Nanowire arrays can detect signals along individual neurons 2
(Date:11/24/2009)...land,November24/PRNewswire-FirstCall/--deCODE,gene...fallofits,"firstday"motionsbytheU.S.BankruptcyCour...eCODElastweekfiledavoluntarypetitionfor,reliefunde...ankruptcyCourt. , TheordersissuedbytheBankrup...nessduringtheChapter11proceedings.Inparticular,the...
(Date:11/24/2009)...24/PRNewswire-Asia/--ShanghaiBiolaxyannouncedthe,C...rovedthe,investigationalnewdrugapplication(IND)for...formulationtotreatdiabetes.ThisIND,approvalallowsB..., Diabetesisadisordercharacteristicofhighbloodgluc...tenresultinseveremicro-and,macro-vasculardiseases,...
(Date:11/24/2009)...cyendpointhasbeenmetforpatientswithadvanced-stage,...v.24/PRNewswire-FirstCall/-AEternaZentarisInc.(NAS...ceuticalcompanyfocusedonendocrinetherapyandoncolog...dywithitstargetedcytotoxicpeptideconjugate,AEZS-10...tendometrialcancer.Inapersonalizedhealthcareapproa...
(Date:11/24/2009)...24,2009/PRNewswire-FirstCall/--ArenaPharmaceutical...yisscheduledtopresentatthePiperJaffray21stAnnualHe...rnTime(8:30a.m.PacificTime)attheNewYorkPalaceHotel...xecutiveOfficer,isscheduledtoprovideanoverviewofth...ryprograms. ,, Aliveaudiowebcastofthepresentati...
Breaking Biology Technology:deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 3Biolaxy Secures IND Approval for Oral Insulin 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4Arena Pharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 2
... Separate Study Also Show Minimal Effect on Heart ...Patients, VIENNA, Austria, Oct. 17 New data show...ng developed by Organon -- is effective,in treatin...isorder. These,results, from two Phase III clinica...ropean College of Neuropsychopharmacology (ECNP) C...
...st time theoretical modeling has provided a glimps... to trap charges, something which may affect the p... revealed in a paper published on the 12th October...London Centre for Nanotechnology and SEMATECH, a c...uest for miniaturization, transistors and all thei...
..., Oct. 16 NxStage Medical,Inc. (Nasdaq: NXTM ), ...ucts, announced plans to release its financial res...r 2, 2007 before the opening of the,financial mark...10:00 a.m. Eastern Time on,November 2, 2007 to dis...listen to the conference call, please dial 800.638...
Other Biology Technology:Organon's Asenapine Further Demonstrates Efficacy in Reducing Mania Symptoms for the Treatment of Bipolar I Disorder 2Organon's Asenapine Further Demonstrates Efficacy in Reducing Mania Symptoms for the Treatment of Bipolar I Disorder 3Organon's Asenapine Further Demonstrates Efficacy in Reducing Mania Symptoms for the Treatment of Bipolar I Disorder 4Organon's Asenapine Further Demonstrates Efficacy in Reducing Mania Symptoms for the Treatment of Bipolar I Disorder 5Organon's Asenapine Further Demonstrates Efficacy in Reducing Mania Symptoms for the Treatment of Bipolar I Disorder 6Novel gate dielectric materials: perfection is not enough 2NxStage(R) Medical to Report Third Quarter 2007 Financial Results on Friday, November 2nd 2
Bsg I from New England Biolabs
Rabbit Anti-CUGBP2 Monoclonal Antibody, Unconjugated, Clone PADZMD.495 from Invitrogen
GIBCO Geneticin Selective Antibiotic liquid from Invitrogen
LB Broth Base powder (Lennox L Broth Base) from Invitrogen
Biology Products: